Accuracy of fine needle aspiration cytology in the diagnosis of bone lesions with radiological assistance: Experience from the National Cancer Institute, Cairo University, Egypt  by Mohamed Aly, Ahmed et al.
The Egyptian Journal of Radiology and Nuclear Medicine (2014) 45, 127–135Egyptian Society of Radiology and Nuclear Medicine
The Egyptian Journal of Radiology andNuclearMedicine
www.elsevier.com/locate/ejrnm
www.sciencedirect.comEDITORIALAccuracy of ﬁne needle aspiration cytology
in the diagnosis of bone lesions with radiological
assistance: Experience from the National Cancer
Institute, Cairo University, Egypt* Corresponding author. Address: National Cancer Institute, Cairo
University, Egypt. Tel.: +20 0100 5663365, +966 53710 5551;
fax: +20 02 23644720.
E-mail address: ahmednasr1971@yahoo.com (A. Mohamed Aly).
Peer review under responsibility of Egyptian Society of Radiology and
Nuclear Medicine.
Production and hosting by Elsevier
0378-603X  2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear Medicine.
http://dx.doi.org/10.1016/j.ejrnm.2013.12.002Open access under CC BY-NC-ND license.Ahmed Mohamed Aly a,*, Hebatallah M. Shaaban b, Iman Abou-Sinna ba Radiology Department, National Cancer Institute, Cairo University, Egypt
b Pathology Department, National Cancer Institute, Cairo University, EgyptReceived 15 June 2013; accepted 1 December 2013
Available online 24 December 2013KEYWORDS
FNAC;
Bone tumors;
Ancillary techniquesAbstract Aim: To evaluate the accuracy of ﬁne needle aspiration cytology in the diagnosis of
bone lesions with radiological assistance.
Patients and methods: 85 cases of FNAC of bone lesions were included. Sixty two procedures were
performed by the radiologist and 23 procedures by the histopathologists. The aspirates were imme-
diately ﬁxed in 95% ethanol alcohol for Papanicolaou staining. If there was sufﬁcient material, cell
block was prepared. Diagnosis was established in 81 cases (95.3%), classiﬁed into 3 categories: (1)
positive for malignant cells (57.6%); (2) suspicious for malignant cells (10.6%); and (3) benign, bor-
derline or inﬂammatory lesions (27.1%). Cytology ﬁndings were compared with subsequent avail-
able histology.
Results: The overall accuracy was 91%. The 49 cases diagnosed as malignant by cytology were all
correct. FNAC could differentiate various giant cell rich lesions and round cell malignancies as
Ewing’s sarcoma, myeloma and NHL. Uncommon bone lesions as chordoma and MFH were also
correctly diagnosed. Cytological diagnosis of benign and borderline lesions was made in 23 patients.
The authors encountered difﬁculties diagnosing a case of MFH that was reported as osteosarcoma
and a case of metastasis that was reported as chondrosarcoma.
128 A. Mohamed Aly et al.Conclusion: FNAC of bone lesions is a simple, safe and accurate diagnostic technique for diagnosis
of bone lesions especially when other diagnostic modalities are unavailable.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Open biopsy is considered the procedure of choice for diagnos-
tic tissue sampling in musculoskeletal (MSK) tumors; however
it requires hospitalization and sometimes surrounding tissue
contamination, infection, hemorrhage or pathological fracture
may occur (1). Percutaneous needle biopsy is also a major tool
in the diagnosis of MSK lesions (2) but it also carries the risk
of bleeding, infection, pneumothorax, spinal cord compression
and neurologic injury. There is a small increase in fracture risk
following bone biopsy, particularly in weight-bearing bones as
the femur (3).
Nowadays; ﬁne needle aspiration cytology (FNAC) is gain-
ing increasing popularity in the diagnosis of MSK lesions (4).
In the majority of patients, the combined evaluation of clinical
and radiologic data together with the FNAC result has been suf-
ﬁcient for making treatment decisions. Only in a minority of pa-
tients, it has been necessary to perform biopsy before deﬁnitive
treatment (5,6). Many speciﬁc MSK tumors either benign or
malignant can be diagnosed correctly by FNAC alone (7).
FNAC of bone lesions has its own advantages of being a
simple, safe, inexpensive, quick outpatient procedure, does
not require hospitalization or general anesthesia, allows preli-
minary diagnosis within 15–20 min of aspiration with very less
possibility of seeding of tumor cells (2). In addition, FNAC
can be safely performed in difﬁcult sites such as the vertebrae
or the pelvis (2).
The main limitation of FNAC in the diagnosis of MSK tu-
mors is that the aspiration specimens do not always yield infor-
mation about tumor tissue architecture and occasionally are
insufﬁcient for ancillary studies (5).
Although large lesions can be easily aspirated without im-
age guidance, many lesions may beneﬁt from image guidance
to improve the accuracy of lesion targeting and improve the
diagnostic yield from subsequent microscopic examination (8).
FNAC was used in this study to examine its role in a
detailed cytodiagnosis of bone lesions, its utility in preopera-
tive diagnosis and its impact on therapeutic decisions.2. Patients and methods
After obtaining the approval of the hospital’s institutional re-
view board (IRB), the study was activated. The study was con-
ducted by the cytology and radiology departments, National
Cancer Institute, Cairo University, Egypt over 3 years period
between August, 2009 and July, 2012. It includes 85 patients
(47 males and 38 females) with age ranged from 4 to 68 years.
Cases were selected on the basis of their clinical presentation
(bony swelling, pain, pathologic fracture) or high radiologic
possibility of bone tumor. ‘Do not touch’ lesions were ex-
cluded from the study. These lesions included post traumatic
lesions as avulsion injury, cortical desmoids and discogenic
vertebral sclerosis; normal variants or lesions which are obvi-
ously benign as non ossifying ﬁbroma, ﬁbrous cortical defect,bone cyst and bone island. The FNAC was done by the cytop-
athologists in 23 cases and the radiologist in 62 cases.
2.1. Protocol of FNAC done by the radiologist
 After reviewing the imaging studies of the patient, the
orthopedic surgeon usually speciﬁes the site for needle
entrance. The relationship of the needle track to the neu-
rovascular structures, tissue planes and future surgery
must be considered before the procedure. The procedure
was done under computed tomography (CT) guidance.
 After explaining the procedure for the patient and tak-
ing an informed written consent, sterilization of the skin
was done by Povidone Iodine 10% W/V followed by
injection of 3 mL of 1% lidocaine local anesthesia sub-
cutaneously and deeply along the tract of the needle.
 In cases where the cortex was intact or in pediatric cases,
I.V analgesia with fentanyl and sedation with midazo-
lam were given and the cortex was penetrated using
Jamshidi needle 9 cm, 13 G or Osteo-Site needle 10 cm,
12 G depending on the depth of the tumor followed by
using 18 G 9 or 12 cm spinal needle attached to a dispos-
able 10 ml plastic syringe for cytology sampling. The
spinal needle was used directly in cases of broken cortex.
In cases of intact cortex, we took cytology sample in
addition to bone biopsy as the aim of this study is to
detect the accuracy of cytology in bone lesions.
 The FNAC sample adequacy is assessed immediately at
the time of collection by the attending cytopathologist.
This immediate interpretation also allows the radiolo-
gist to redirect his approach as well as to obtain addi-
tional samples for ancillary studies. This obviates the
need for the patient to return for rebiopsy.2.2. Protocol of FNAC done by the cytopathologist
 The imaging studies of the patient were reviewed by the
radiologist and the performing cytopathologist to
choose the best track for sampling to avoid sampling
a necrotic area.
 FNAC was done by the cytopathologist in cases where
the cortex was signiﬁcantly broken over a large area of
the bone or the bone lesion was associated with palpable
soft tissue component, so there was no need for image
guidance to do the procedure.2.3. Protocol of sample processing by the cytopathologist
 The aspirates were spread on frosted-ended glass slides,
immediately ﬁxed in 95% ethanol alcohol for modiﬁed
Papanicolaou staining which has the advantage of
better nuclear detail and ease of comparison with
histological sections. If there was sufﬁcient material, cell
block was prepared after centrifugation.
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classify the cellspresent suchas epithelial, hematolymphoid
or mesenchymal and to subtype the lesion when possible.
 At ﬁnal reading, the modiﬁed Papanicolaou stained
smears, the hematoxylin and the eosin-stained sections
of the available cell block were evaluated.
 In cases of Ewing sarcoma; genetic studies were per-
formed for conﬁrmation.
 The provisional diagnosis was meticulously interpreted
in conjunction with the results of the available IHC stud-
ies to render a ﬁnal diagnosis. The cytological diagnoses
were classiﬁed into 1 of the 4 categories: (1) positive for
malignant cells, and deﬁning the type of malignancy and
whether it is primary or metastatic; (2) suspicious for
malignant cells or neoplasm; (3) benign, borderline or
inﬂammatory lesions; and (4) inadequate or less than
optimal for evaluation. Diagnosis of ‘‘suspicious for
malignancy’’ was made when abnormal cells were
observed, but the diagnostic material was limited for a
deﬁnitive diagnosis of malignancy. Diagnosis of ‘‘Inade-
quate’’ was rendered when smears were acellular or con-
sisted of blood and/or rare ﬁbroblasts. The ﬁndings of
FNAC were compared with the subsequent available
histologic diagnoses and with the available ancillary
techniques. Wherever possible, an attempt was made
to reach an exact deﬁnite cytological diagnosis.
3. Results
The clinicopathologic characteristics of the 85 cases are
summarized in Table 1. Material sufﬁcient for diagnosis was
obtained in 81 (95.3%) cases. The most frequent aspirated site
was the femur. The scapula was the most frequent bone and
gave inadequate samples. The femur, vertebrae, tibia and pel-
vis gave satisfactory smears. Detailed cytologic diagnoses were
given only after complete study.
3.1. Diagnostic accuracy
Correlation was available for 66 (77.6%) out of the 85 cases,
including 44 cases (89.8%) of 49 that were labeled cytologically
malignant, 9 (39%) of 23 that were labeled benign and border-
line on cytology and all 13 cases in the suspicious and inade-
quate categories.
Correlation was available by the way of histology in 44 out
of the 66 cases (66.6%) or by (IHC) in 19 cases (28.8%)
applied on the available cell block material and by serumTable 1 Clinicopathological characteristics of the 85 cases of bone
Cytodiagnosis No. (%) Age range (yrs) Sex
Positive for malignancy 49 (57.6%) 4–62 M-28; F-21
Suspicious for malignancy 9 (10.6%) 22–47 M-3; F-6
Inadequate for diagnosis 4 (4.7%) 45–68 M-2; F-2
Benign, borderline and
inﬂammatory lesions
23 (27.1%) 18–57 M-14; F-9
Total 85 (100%) 4–68 M-47; F-38electrophoresis in 3 cases of plasma cell myeloma (4.6%)
(Table 2). Cytologic diagnosis was conﬁrmed in 60 out of the
66 patients with available correlation, giving a diagnostic accu-
racy of (91%) (Table 3).
The diagnostic errors in this study were in 2 cases; a case of
(MFH) that was reported as osteosarcoma and a case of
metastatic breast carcinoma that was reported as chondrosar-
coma. All 9 cases (10.6%) cytologically diagnosed as ‘‘suspi-
cious for malignancy’’ proved to be malignant lesions; 2
were osteosarcomas, 1 was angiosarcoma, 1 ﬁbrosarcoma
and 5 were metastatic neoplasms.
3.2. Details on discordant cases
In one patient, a diagnosis of osteosarcoma was made but the
surgical biopsy came out as MFH. This patient was a 14 year
old male with a lesion in the upper metadiaphysis of the femur.
Cytology correctly identiﬁed this as a malignant lesion but not
the type. The histopathology sections have shown that the foci
of neoplastic osteoid seen in the FNAC smears were in fact
irregular coarse collagen ﬁbers. In the second patient, a pelvic
metastatic breast carcinoma was misinterpreted by FNAC as a
chondrosarcoma. On review, this case showed scant cytologic
material formed of atypical malignant cells, varying in size and
shape and contain enlarged, hyperchromatic nuclei in a myx-
oid background. History of breast carcinoma was not avail-
able at the time of aspiration.
3.3. Primary malignant tumor
Follow up of our cases conﬁrmed that 34 out of the 85 cases
(40%) were primary malignant neoplasms. The most frequent
type was osteosarcoma (Table 4). Smears were of low to moder-
ate cellularity, featured pleomorphic malignant cells, dispersed
singly as well as in small clusters and groups (Fig. 1). These
markedly anaplastic, rounded and spindled shaped cells had
moderate to abundant cytoplasm and large pleomorphic hyper-
chromatic nuclei with occasionally prominent nucleoli. Atypical
mitoses are abundant. Malignant giant cells both mono and
multinuclear were also frequent. Background showed faintly
eosinophilic, amorphous aggregates of osteoid. In 8 out of the
10 cases of osteosarcoma, osteoid or osteoid-like material was
appreciated along with pleomorphic cells render the diagnosis
of osteosarcoma feasible. The smears of the chondroblastic
variant of osteosarcoma (2 of 10) showed an abundant chondr-
omyxoid material in the background along with round to
polygonal cells embedded in this material. This picture was
similar to that encountered in high grade chondrosarcoma.lesions diagnosed by FNAC.
Sites involved
Femur(18) tibia(7) pelvis(7) Vertebra(6) humerus (3) multiple
bones (3) scapula(2) clavicle(2) skull(1)
Vertebra(3) femur(2) humerus(2) clavicle(1) scapula(1)
Scapula(3) ﬁbula(1)
Femur(6) maxilla(3) tibia(3) pelvis(3) skull(3) phalanx(2)
vertebra(2) scapula(1)
Femur(26) vertebra(11) tibia(10) pelvis(10) scapula(7) humerus(5)
skull(4) clavicle(3) multiple bones(3) maxilla(3) phalanx(2)
ﬁbula(1)
Table 2 Accuracy of speciﬁc cytological diagnosis of bone tumors in 66 patients with available correlation.
Cytological Diagnosis No. of cases
diagnosed with
FNAC
No. of cases
diagnosed by
histopathology
No. of cases conﬁrmed by other means* No. of cases
conﬁrmed
as benign
No. of cases
conﬁrmed as
malignant
Primary malignant tumor
Ewing sarcoma 8 3 5 cases +ve for CD99 & ve for LCA &
desmin
none 8
Osteosarcoma 11 11 – none 11
Chondrosarcoma 7 7 – none 7
Plasma cell myeloma 3 – 3 cases by serum electrophoresis none 3
MFH 3 3 – none 3
NHL 2 – 2 cases + ve for LCA, CD20 – 2
Chordoma 1 1 – – 1
Total 35 25 10 none 35
MBT 14 – 9 cases. 2 cases + ve for GCDFP-15, 2
cases + ve for Cdx-2. one case + ve for
CK7, two cases + ve for TTF-1 and two
cases + ve for PSA
none 9
Benign & borderline cases 23
GCT 5 4 – 4 none
Langerhans cell histiocytosis 4 – 3 cases + ve for CD1a 3 none
Benign lipomatous lesions 3 – – – –
Hemangioma 3 – – – –
ABC 3 2 – 2 none
Inﬂammatory conditions 5 – – – –
Suspicious for malignancy 9 9 – – 9
Inadequate 4 4 – 2 2
Total 85 44 22 11 55
MFH: malignant ﬁbrous histiocytoma GCT: Giant cell tumor ABC: Aneurysmal bone cyst; NHL: Non Hodgkin’s Lymphoma MBT: Meta-
static bone tumor.
* Immunohistochemistry or serum electrophoresis.
Table 3 Diagnostic accuracy of the conﬁrmed (66) cases.
FNAC diagnosis No of
cases
Follow up Reason for error Diagnostic
accuracy (%)
Osteosarcoma 1 MFH Interpretative (8 of 9) 89%
Chondrosarcoma 1 Metastatic lobular carcinoma Defective clinical &radiological correlation (8 of 9) 89%
Inadequate 4 Osteosarcoma(1) Ewing’s sarcoma(1)
GCT (1) ABC(1)
Sampling error (0 of 4) 0%
Total 6 (60 of 66) 91%
MFH: malignant ﬁbrous histiocytoma GCT: Giant cell tumor ABC: Aneurysmal bone cyst.
Table 4 Forty-nine malignant cases diagnosed by FNAC.
Diagnosis No. of cases (%)
Primary malignant tumor 34 (69.3)
Osteosarcoma 10 (20.4)
Ewing sarcoma 8 (16.3)
Chondrosarcoma 6 (12.2)
Plasma cell myeloma 3 (6)
NHL 2 (4.1)
Malignant ﬁbrous histioytoma 4 (8.2)
Chordoma 1 (2.1)
Metastatic bone tumor 15 (30.7)
Adenocarcinoma 10 (20.4)
Squamous cell carcinoma 2 (4.1)
Small cell carcinoma 2 (4.1)
Melanoma 1 (2.1)
Total 49 (100)
130 A. Mohamed Aly et al.Chondrosarcoma showed gelatinous material on aspiration,
diagnosed cytologically in all 6 patients after integration of clin-
ical and radiologic information. Five cases were of low grade
and one case of high grade. The low grade chondrosarcomas,
showed mildly atypical chondroid cells sitting in lacunae with
abundant chondromyxoid matrix. Dissociated single cells were
relatively fewer in number. Mitotic ﬁgures are less frequently
encountered. The high grade tumors in contrast showed
predominantly dissociated cells in a less frequent matrix. Cells
are round to polygonal with a variable amount of dense often
vacuolated cytoplasm. Binucleate andmultinucleate cells as well
as mitotic ﬁgures were more frequent.
The smears in Ewing sarcoma were cellular and showed
malignant small round cells dispersed singly and arranged in
loose clusters and rosettes (Fig. 2). The cells had scanty
cytoplasm and round nuclei with ﬁne granular chromatin
and inconspicuous nucleoli. Five cases showed positive
Fig. 1 Osteosarcoma (a) Malignant cells showing nuclear pleomorphism, with (b) large tumor giant cells (Papanicolaou stain, a. X200,
b. X400). The plain X-Ray of the right knee (c) shows mainly sclerotic bone lesion in the metadiaphysis of the femur (solid arrow)
associated with soft tissue component (arrow head) and the characteristic Codman’s triangle (thin long arrow). Coronal T1 image (d)
shows the medullary sclerotic bone lesion (thin long arrow) and the soft tissue component (solid arrow). The characteristic age of the
patient (18 year old) and the characteristic imaging features are consistent with osteosarcoma.
Accuracy of ﬁne needle aspiration cytology in the diagnosis of bone lesions with radiological assistance 131reaction to CD99 and negative reaction to LCA and desmin
conﬁrming the diagnosis of Ewing sarcoma. Therapeutic deci-
sion was taken on the base of FNAC only and neoadjuvant
chemotherapy started immediately without pathological
conﬁrmation.
MFHsmears consistedmainly of amixed population of spin-
dle cells, histiocytoid andpleomorphic cells. Varying amounts of
multinucleated giant cells of the osteoclast type are seen with
foamy cells and chronic inﬂammatory cells. The nuclei of the
tumor cells may be quite atypical, particularly in the malignant
giant cells. Typical and atypical mitoses are present (Fig. 3).
The smears from the three cases of plasma cell myeloma
were composed of numerous plasma cells with varying degrees
of maturation. All the cases showed an M band on serum elec-
trophoresis. A case of chordoma was diagnosed in a 50 year
old male with a sacral tumor. Smears showed numerous vacu-
olated cells (physaliferous cells) in a myxoid background.
3.4. Metastatic bone tumors (MBT)
Fifteen cases (30.6%) proved to be metastatic neoplasms
(Table 4) (Fig. 4). Nine cases (60%) had relevant radiological
and clinical ﬁndings and conﬁrmedwith IHC study. Surgical fol-
low up was available for the case mistyped as chondrosarcoma
by FNAC. The most frequently aspirated sites demonstrating
MBT were vertebral and pelvic bones. The most frequent typeof metastatic carcinoma was adenocarcinoma (10 cases). In 9
cases, the primary site was conﬁrmed by IHC panel. Three cases
were positive for GCDFP-15 supporting a primary breast ori-
gin. Two cases showed positive reaction for Cdx-2 and negative
reaction for GCDFP-15 supporting the colonic origin. In two
cases, the tumor cells stained positively with TTF-1 and showed
no IHC reaction for GCDFP-15 and Cdx-2, supporting pul-
monary adenocarcinoma as primary. Two cases showed positiv-
ity to prostate speciﬁc antigen (PSA). The remaining 5 cases
whichwere not subjected to IHCdue to deﬁcient cytologicmate-
rial, morphology together with the available history conﬁrmed
the diagnosis of metastasis (2 cases of squamous cell carcinoma
of laryngeal and bladder origin, 2 cases of primary soft tissue
sarcoma, and 1 case of malignant melanoma).
3.5. Benign, low grade tumors and inﬂammatory lesions
Twenty three out of 85 (27.1%) cases were benign or low grade
tumors (Table 1). Giant cell tumorwas themost frequently iden-
tiﬁed lesion. The smears showed abundant round to oval polyg-
onal or elongated mononuclear cells evenly mixed with
numerous osteoclasts-like giant cells which may be very large
and contain 50–100 nuclei. Radiographic ﬁndings (epiphyseal
lytic lesion of long bones without perilesional sclerosis) and
clinical characteristics (youngadults) allowed for deﬁnitive diag-
nosis in the all 5 cases.
Fig. 2 Ewing sarcoma. Plain X-Ray of the right ankle in frontal view (a) of a 17 year old male shows sclerotic bone lesion in the the
medulla of the lower diaphysis of the ﬁbula (long arrow). The normal medulla is radiolucent (short thick arrow). The lesion is associated
with speculated ‘sunray’ periosteal reaction and soft tissue shadow (arrow heads). Coronal T1 WI (b) shows inﬁltrative hypointense lesion
(arrow). The epiphysis shows normal fatty marrow (arrow head). Post contrast axial T1 WI (c) shows soft tissue mass (arrow) surrounding
the bone lesion with areas of breaking down (arrow head). Radiologically; the picture is consistent with Ewing sarcoma. FNAC conﬁrms
the diagnosis (d) small round cells dispersed singly and forming loose clusters with frequent rosettes (e) Cell blocks section of the same case
(f) The cells show positive immunohistochemical reaction to CD99 (d. Papanicolaou stainX200; e. H&E X200; f. immunostainX400).
132 A. Mohamed Aly et al.The smears from Langerhans cell histiocytosis cases were
composed of Langerhans cells with its characteristic folded
or grooved nuclei. Admixed with the Langerhans cells are
eosinophils, lymphocytes, neutrophils and plasma cells.
CD1a conﬁrms the diagnosis in 3 cases of them.
Three cases of (ABC) showed low cellularity and plenty of
blood. Spindle cell clusters and osteoclastic giant cells were
seen with hemosiderin laden macrophages and osteoblasts.
Radiology played a major role in the diagnosis of these cases.
The remaining benign cases were reported as negative for
malignant cells with a comment statement describing the sub-
category or subclassiﬁcation of the lesion and the most likely
differential diagnosis. The benign lipomatous lesions included
classic lipoma, ﬁbrolipoma, and angiolipoma. The inﬂamma-
tory lesions include acute and chronic inﬂammation, abscess
and granulomatous inﬂammation.
3.6. Suspicious and inadequate cases
We recommended histopathologic examination for all our sus-
picious and inadequate cases (13 cases, 15.3%). Subsequent
histopathology of the 9 suspicious cases conﬁrmed their malig-
nant nature (3 metastatic carcinomas, 4 sarcomas and 2 NHL).Core biopsies were done for the 4 inadequate cases; their
histopathologic examination came out to conﬁrm 2 of them
as malignant (osteosarcoma and Ewing sarcoma). The other
2 cases included 1 GCT case and 1 ABC case.4. Revised discussion
Nowadays, medical imaging is an integral part in the patholog-
ical assessment of bone lesions as well as for localizing the area
to be aspirated (4).
Compared to other methods, FNAC has been found to be a
successful and safe method in the diagnosis of different bone
lesions and it is usually possible to separate benign from malig-
nant lesions and to subtype the malignancy (9).
Sampling errors of FNAC are due to low cellularity, inad-
equate sampling and copious cystic/bloody/necrotic material
(10). However; FNAC is still used as a diagnostic modality
for initial diagnoses and for recurrent and metastatic bone le-
sions in many centers (11–15). Treatment can be initiated with-
out any delay, as the aspiration wound is not endangered and
the possibilities of limb salvage improve as there is less disrup-
tion of the soft tissues and the affected bone (16).
Fig. 3 MFH. Frontal plain X-Ray of the right hip (a) of a 14 year old male shows bone lesion in the femoral neck, intertrochanteric
region and upper part of the diaphysis with sclerotic focus in the epiphysis (arrow head). The lesion has lytic (black arrow) and sclerotic
(white arrows) components. Coronal reformatted CT image (b) conﬁrms the sclerotic part of the lesion (black arrow) and the lytic
component (white arrow) with sclerotic focus in the epiphysis (arrow head). Coronal T1 WI (c) and coronal STIR (d) show hypointense
signal of the sclerotic part in all pulse sequences (white arrows) while the lytic part shows hypointense signal in T1 and hyperintense signal
in T2 WIs (white arrow head). Radiologically, the lesion was diagnosed as osteosarcoma but FNAC comes as MFH (e) Sheet of spindle to
ovoid cells, some of them show histiocytoid appearance (f) Pleomorphic malignant cells admixed with foamy cells and chronic
inﬂammatory cells (Papanicolaou stain, e&f. X200).
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rates as high as 95% have been described by Bommer et al.,
Mehrotra et al. and Jorda et al., (11,14,16). Adequacy of the
aspirate plays an important role in deciding this rate, which in
turn depends on the site, characteristics, histological grade of
the tumor and adequacy of the clinical and radiologic data (17).
In many studies as those done by Nnodu et al., Layﬁeld and
Eyre et al., (1,15,18) and in our study, osteosarcoma was the
commonest primary malignant tumor. The clinical presenta-
tion, the characteristic radiologic picture and the characteristic
cytological features previously mentioned (Fig. 1A and B),
were mandatory and enough for reaching the diagnosis. All
cases of osteosarcoma (n= 10) were diagnosed by these col-
laborative studies and were conﬁrmed by histopathology after
excision of the tumors. In one case, the morphologic features
were that of malignancy but typing as osteosarcoma was not
conclusive due to absence of osteoid.
It was difﬁcult to distinguish our two cases of chondroblas-
tic variant of osteosarcoma from high-grade chondrosarcoma.
Such distinction was probably due to young age of the patient
(12 and 16 year old) together with metaphyseal involvement of
the affected bones and relatively more nuclear hyperchromasia
and pleomorphism.The second most frequent primary malignant bone tumor
in our study was Ewing sarcoma (8 out of 34 cases) forming
23.5% of the primary malignant cases. The reported incidence
in the literatures varied widely from 6% in the study done by
Chow et al., (19) to 39% in a study done by Eyre et al., (18)
which could be due to different age groups of each study.
The characteristic age and radiographic ﬁndings suggest the
diagnosis but unfortunately, cytomorphologic features cannot
differentiate Ewing sarcoma from other blue round cell tu-
mors, mainly lymphoma. Accordingly, immunocytochemistry
on cell blocks, tissue biopsy and IHC were needed for conﬁr-
mation. The cytological diagnosis was conﬁrmed by immuno-
cytochemical panel in 62.5% of the cases and by tissue biopsy
and IHC in the remaining 37.5%.
Chondrosarcoma forms 17.6% of all primary tumors in our
study which is comparable to 20% reported by Flemming et
al., (20). The 6 cases cytologically diagnosed as chondrosar-
coma were conﬁrmed histopathologically except 1 case which
was proved to be metastatic lesion histopathologically. This
happened due to lack of history of primary cancer with
insufﬁcient radiological ﬁndings together with the subtle
morphologic features of tumor cells that present as separate
round and oval cells with mild atypical nuclear features.
Fig. 4 Metastatic bone tumor. (a) X-Ray of the left humerus shows osteolytic bone lesion of the shaft with ‘moth eaten’ appearance. In
view of the patient history of primary carcinoma, metastatic deposit was diagnosed (b) metastatic colonic adenocarcinoma (c) tumor cells
positive for CDX2 (d) metastatic breast ductal carcinoma (e) Tumor cells positive for GCDFP-15 (Papanicolaou stain, a. X400; d. X200;
immunostain, c. X200, e. X400). FNAC proves metastasis.
134 A. Mohamed Aly et al.Plasmacytoma represents 8.8% of our cases. This is concor-
dant with 8.3% observed by Shah et al., (21). Cytological
smears of the 3 cases showed typical plasma cells making
correct diagnosis. Serum electrophoresis was helpful in the
diagnosis.
Excellent cytological details obtained byFNAC inMFHand
the accuracy of the results make FNAC a highly reliable proce-
dure in the diagnosis of this tumor (22). Chordomas (11,23) and
NHL (24) are also easily diagnosed by this technique.
Metastatic bone tumors (MBT) accounted for 17.6% (15
out of 85 cases) in our study, which is less than the ﬁgures re-
ported by Nnodu et al., and Jorda et al., which were 44% and
28.1% respectively (1 and 16). This is due to that radiology
alone with history of primary tumor are considered enough
for diagnosing MBT in our institute. Previous studies done
by Jorda et al., and James et al., showed the high diagnostic
accuracy of FNAC in MBT (16,25). In our series, 93.3% (14
out of 15 cases) of MBT were correctly diagnosed by FNAC
due to the presence of primary malignancy and the familiarity
with the previous morphology of the known malignancy.
Twenty three out of 85 cases (27%) were benign and bor-
derline. This is lower than the 38% reported by Moatasim
et al (26). GCT and inﬂammatory bone lesions formed the
majority of these cases (5 cases each). The frequency of GCT
in our study is slightly lower than the 28% reported by Eyesan
et al (27) which could be due to the relatively larger total
number of cases in our study. The benign lesions included in
this study did not show typical benign radiological picture;
thus FNAC was done.The characteristic radiological picture of GCT plays a
crucial role in the diagnosis presenting as eccentric subchon-
dral lytic lesion reaching the metaphysis with no periosteal
reaction or mineralized matrix (28). These features together
with the cytomorphologic features raised the diagnosis of
GCT in our 5 cases with histopathology conﬁrmation in 4
of them.
The differential diagnosis between osteomyelitis and
neoplasm may be difﬁcult clinically and radiologically, there-
fore the results of bacterial culture and cytologic presence of
inﬂammatory cells help to establish the diagnosis of
osteomyelitis (1).
The more problematic group is the inadequate samples
group. There are no established adequacy criteria for FNAC.
Thus, the number of inadequate cases varies from a study to
another. One study deﬁned adequacy as the presence of at least
5 clusters of 10 unobscured cells on the majority of the slides
(4). The rate of inadequate aspirates, ranging from 0% in a
study done by Layﬁeld et al (29) to 33% in s study done by
Dollahite et al (30), compares favorably with the rate pub-
lished for open or cutting core needle biopsies (31,32).The
presence of a cytopathologist during the FNAC procedure
should reduce the percentage of inadequate aspirates as the
case in our study which can partially explain our low rate
(4.7%) of insufﬁcient aspirates. The variability in reported
inadequacy rates also depends on the number of cases in the
study. In fact, the highest reported inadequacy rate was
reported in a study with no onsite evaluation, where 97 of
314 cases (31%) were deemed inadequate (16).
Accuracy of ﬁne needle aspiration cytology in the diagnosis of bone lesions with radiological assistance 1355. Conclusion
When sampling is adequate and the clinicoradiologic ﬁndings
are available, FNAC of bone lesions is a highly accurate and
diagnostic technique. Inﬂammatory conditions, non-ﬁbrotic
bone lesions, benign tumors as well as primary and metastatic
malignant tumors can be correctly diagnosed by FNAC. Con-
sidering the overall advantages and cost-analysis, FNAC may
be suggested as the initial method of choice for evaluation of
bone lesions in most clinical settings.Conﬂict of interest
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